L-ascorbic acid/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases C-reactive protein concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Ascorbic acid significantly reduced the proinflammatory biomarkers C-reactive protein and procalcitonin.”
Quoted verbatim from Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis.. - Study
- RCT
- Duration
- 4 days
- Dose
- 50 mg/kg/24 h or 200 mg/kg/24 h intravenously, infusions every six hours for four days
- Population
- 24 patients with severe sepsis in a medical intensive care unit; low-dose and high-dose ascorbic acid arms versus placebo (5% dextrose/water)
Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis.2014PMID:24484547Permalink
Keep reading
- Everything the graph holds on L-ascorbic acid
- Every compound studied against C-reactive protein concentration
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4QFN3FRZ737D51WXZNMCDE9